Johnson & Johnson news

   Watch this stock
Showing stories 11 - 20 of about 131   

Articles published

JNJ 98.96 +0.21 (0.21%)
price chart
Johnson & Johnson Is A Healthy Stock In A Volatile Market
With many momentum stocks appearing to peter out, investors could do a lot worse than investing in a blue chip stock like Johnson & Johnson (JNJ) when it's valued at such a cheap price. Diversification & Consistent Profits. JNJ sells a massive variety ...
Related articles »  
Johnson & Johnson Tops Street Views Amid Strong Drug Sales
Johnson & Johnson (JNJ) said Tuesday its first-quarter profit surged 35%, as sales growth in its pharmaceutical business helped the healthcare giant beat Wall Street expectations.
Dow Today: Johnson & Johnson (JNJ) Lower
Holding back the Dow today is Johnson & Johnson (NYSE:JNJ), which is lagging the broader Dow index with a 51-cent decline (-0.5%) bringing the stock to $98.69.
Does Johnson & Johnson Belong in Your Portfolio?
Johnson & Johnson engages in the research and development, manufacturing, and sale of various products in the healthcare field worldwide.
Johnson & Johnson's Earnings Report Impresses
If you're going to have a "messy" quarter, you probably couldn't do it much better than Johnson & Johnson (NYSE: JNJ ) did in the first quarter. Devices and Consumer continue to log disappointing results, but the higher-margin Pharma business is more ...
Stocks to Watch: Coca-Cola, Johnson & Johnson, Zebra Technologies
Johnson & Johnson said its first-quarter earnings rose 35% led by sales growth in the health-products giant's pharmaceutical business.
Johnson & Johnson Ending Plans for Botox Rival
Johnson & Johnson Ending Plans for Botox Rival. Health-Care Company Acquired Wrinkle Fighter PurTox in $1.1 Billion Purchase of Mentor.
J&J says halting development of Botox rival  Reuters
Related articles »  
Johnson & Johnson Accepts Carlyle's Bid for Blood-Testing Unit
New Brunswick, N.J.-based J&J, which makes everything from prescription drugs and medical devices to Band Aids and Listerine mouth wash, has been shedding slow-growing products and businesses.
Johnson & Johnson Inks $4B Sale of Ortho Arm to Carlyle  Fox Business
J&J Accepts $4 Billion Offer From Carlyle for Ortho Unit  Bloomberg
Related articles »  
One Put, One Call Option To Know About for Johnson & Johnson
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson Johnson & Johnson (NYSE: JNJ). So this week we highlight one interesting put contract, and one interesting call ...
Related articles »  
Why Johnson & Johnson Treasures BabyCenter's Data
Johnson & Johnson has improved on its ability to target its advertising and develop brand strategies thanks to some internal initiatives (and an assist from an agency).